NCT04056429View on ClinicalTrials.gov

Multiregion BHA in Open Tibia Fractures

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

July 31, 2026

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions

Tibial Fractures

Interventions

COMBINATION_PRODUCT

BHA

BHA active ingredients include beta-tricalcium phosphate and a blood-derived component. It is applied directly to the bone fracture and nearby viable bone at the time of wound closure.